Enavate Launches With $300m To Help Drug Developers Get Over Funding Hurdles

Patient Square Is Sole Initial Investor

 
• By Mandy Jackson

The firm, helmed by former life science investment banker James Boylan, views the current difficult financial market as the perfect time to offer its expertise and capital to growing companies.

Businessman jumping on chart columns
Growing companies face a chilly market, which is where Enevate hopes to step in • Source: Alamy

More from Financing

More from Business